Clin2
NCT07021430Possibly a fitRecruiting

Preventing Malaria in Pregnancy with Focal Drug Treatment

Malaria Prevention

Treatments studied

Part of Infections clinical trials.

This trial tests whether giving a malaria prevention drug (DHA-PQP) to pregnant women in Kasese District can reduce malaria in pregnancy. Pregnant women at Bugoye Health Center who are less than 22 weeks along may join.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
300 people
Ages
Any age
Study type
Interventional

Who can take part

  • You live in Kasese District for at least 6 months of the year and plan to stay for the next 6 months.
  • You are pregnant, at least 18 years old, and less than 22 weeks along.
  • You plan to get prenatal care and give birth at Bugoye Level III Health Center.
  • You do not have HIV.
  • You are willing to take study medication and follow study procedures.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07387341Not yet recruiting
Mosquito repellent trial for children

This trial tests a mosquito repellent that is placed in homes to see if it helps prevent malaria. It is for children living in the area.

Kisumu
NCT06962319Recruiting· Phase 3
Malaria treatment safety in early pregnancy

This trial tests how safe antimalarial drugs are during the first few months of pregnancy. It aims to find treatments that protect both mother and baby.

Nanoro
NCT07389057Recruiting
Malaria prevention study with combined medicines in Ghana

This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.

Accra, Eastern Region
NCT07322068Not yet recruiting· Phase 4
Preventing malaria in children in Busia, Uganda

This study tests if adding malaria prevention medicine to a vaccine schedule can better protect children from malaria. It is for healthy children living in Busia District, Uganda.

Busia District
NCT07060404Not yet recruiting· Phase 2/Phase 3
Breast milk study of malaria medicine after childbirth

This study measures how a medicine called an 8-aminoquinoline passes into breast milk after birth, to help prevent malaria in new mothers. If you and your baby have normal G6PD levels and you plan to exclusively breastfeed, this trial may be for you.

Madang, Madang Province
NCT07246525Not yet recruiting· Phase 4
Malaria prevention pills for school children

This trial tests giving school-age children a short course of medicine to prevent malaria and see if it can reduce the spread of the disease in the community. It involves taking pills at set times during the school year.

Kampala

Hear when a new Malaria Prevention trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.